{"id":21406,"date":"2025-09-19T12:35:26","date_gmt":"2025-09-19T12:35:26","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=21406"},"modified":"2025-09-19T12:35:26","modified_gmt":"2025-09-19T12:35:26","slug":"fujifilm-and-argenx-extend-collaboration-to-u-s-operations","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/","title":{"rendered":"\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u3068argenx\u3001\u7c73\u56fd\u3067\u306e\u5354\u696d\u3092\u62e1\u5927"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding its partnership with argenx SE, an immunology firm. Under the new agreement, FUJIFILM Biotechnologies will start making the drug substance for argenx&rsquo;s efgartigimod. This will take place at its Holly Springs, North Carolina, site beginning in 2028.<\/p><p>argenx is the first tenant in FUJIFILM Biotechnologies&rsquo; Phase II expansion at Holly Springs. This expansion will add eight more bioreactors. Each one holds 20,000 liters. They will join the eight already on-site.<\/p><p>Efgartigimod is a monoclonal antibody (mAb) fragment. It targets the neonatal Fc receptor (FcRn) to treat severe autoimmune diseases. It is approved worldwide as VYVGART&reg; and VYVGART&reg; Hytrulo. This treatment is for adults with generalized myasthenia gravis (gMG) or chronic inflammatory demyelinating polyneuropathy (CIDP). Both are lasting autoimmune disorders. They cause severe muscle weakness.<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rohto-pharma-builds-global-platform-with-dynamics-365\/\" rel=\"bookmark\">\u30ed\u30fc\u30c8\u88fd\u85ac\u3001Dynamics 365\u3067\u30b0\u30ed\u30fc\u30d0\u30eb\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u69cb\u7bc9<\/a><\/h4><p>\u3053\u306e\u65b0\u3057\u3044\u88fd\u9020\u5951\u7d04\u306b\u3088\u3063\u3066\u3001 <a href=\"https:\/\/argenx.com\/\" data-no-translation=\"\">argenx SE<\/a> \u3092\u5229\u7528\u3057\u307e\u3059\u3002 <a href=\"https:\/\/fujifilmbiotechnologies.fujifilm.com\/\" data-no-translation=\"\">FUJIFILM Biotechnologies<\/a>&rsquo; kojoX&trade; network. This network offers local manufacturing near patient populations. The kojoX network is the biggest modular manufacturing platform in the industry. It offers flexible clinical and commercial capacity from locations in the U.S., the U.K., Denmark, and FUJIFILM Group&rsquo;s site in Japan.<\/p><p>\u30d4\u30fc\u30bf\u30fc\u30bb\u30f3\u306f\u3001kojoX\u306e\u88fd\u9020\u65b9\u6cd5\u304c\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u5f3e\u529b\u6027\u3092\u9ad8\u3081\u308b\u3068\u6307\u6458\u3002\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u30d1\u30fc\u30c8\u30ca\u30fc\u304c\u5fc5\u8981\u3068\u3059\u308b\u30b9\u30d4\u30fc\u30c9\u3068\u67d4\u8edf\u6027\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u91cd\u8981\u306a\u6cbb\u7642\u304c\u4e16\u754c\u4e2d\u3067\u30b9\u30e0\u30fc\u30ba\u306b\u63d0\u4f9b\u3055\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding its partnership with argenx SE, an immunology firm. Under the new agreement, FUJIFILM Biotechnologies will start making the drug substance for argenx&rsquo;s efgartigimod. This will take place at its Holly Springs, North Carolina, site beginning in 2028.argenx is the first tenant in FUJIFILM Biotechnologies&rsquo; Phase II expansion at Holly Springs. This expansion will add eight more bioreactors. Each one holds 20,000 liters. They will join the eight already on-site.Efgartigimod is a monoclonal antibody (mAb) fragment. It targets the neonatal Fc receptor (FcRn) to treat severe autoimmune diseases. It is approved worldwide as VYVGART&reg; and VYVGART&reg; Hytrulo. This treatment [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":21407,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,207,237,182],"tags":[8003,3503,8002,346,424],"ppma_author":[572],"class_list":["post-21406","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-international","category-news","category-pharma","tag-argenx-se","tag-biotechnology","tag-fujifilm-biotechnologies","tag-manufacturing","tag-pharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FUJIFILM Biotechnologies Expands argenx Deal to U.S. Sites<\/title>\n<meta name=\"description\" content=\"FUJIFILM Biotechnologies expands partnership with argenx, beginning U.S. manufacturing of efgartigimod drug substance in 2028.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FUJIFILM Biotechnologies Expands argenx Deal to U.S. Sites\" \/>\n<meta property=\"og:description\" content=\"FUJIFILM Biotechnologies expands partnership with argenx, beginning U.S. manufacturing of efgartigimod drug substance in 2028.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T12:35:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/FUJIFILM-Biotechnologies-Expands-Strategic-Partnership-with-argenx-to-Include-U.S.-Manufacturing-Operations.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30ba\u3001argenx\u793e\u3068\u306e\u5951\u7d04\u3092\u7c73\u56fd\u306b\u62e1\u5927","description":"\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30ba\u3001argenx\u793e\u3068\u306e\u63d0\u643a\u3092\u62e1\u5927 2028\u5e74\u306b\u30a8\u30d5\u30ac\u30eb\u30c1\u30ae\u30e2\u30c9\u539f\u85ac\u306e\u7c73\u56fd\u88fd\u9020\u3092\u958b\u59cb.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/","og_locale":"ja_JP","og_type":"article","og_title":"FUJIFILM Biotechnologies Expands argenx Deal to U.S. Sites","og_description":"FUJIFILM Biotechnologies expands partnership with argenx, beginning U.S. manufacturing of efgartigimod drug substance in 2028.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/","og_site_name":"itbusinesstoday","article_published_time":"2025-09-19T12:35:26+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/FUJIFILM-Biotechnologies-Expands-Strategic-Partnership-with-argenx-to-Include-U.S.-Manufacturing-Operations.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"FUJIFILM and argenx Extend Collaboration to U.S. Operations","datePublished":"2025-09-19T12:35:26+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/"},"wordCount":244,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/FUJIFILM-Biotechnologies-Expands-Strategic-Partnership-with-argenx-to-Include-U.S.-Manufacturing-Operations.webp","keywords":["argenx SE","Biotechnology","FUJIFILM Biotechnologies","Manufacturing","Pharma"],"articleSection":["Health Tech","International","News","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/","name":"\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30ba\u3001argenx\u793e\u3068\u306e\u5951\u7d04\u3092\u7c73\u56fd\u306b\u62e1\u5927","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/FUJIFILM-Biotechnologies-Expands-Strategic-Partnership-with-argenx-to-Include-U.S.-Manufacturing-Operations.webp","datePublished":"2025-09-19T12:35:26+00:00","description":"\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30ba\u3001argenx\u793e\u3068\u306e\u63d0\u643a\u3092\u62e1\u5927 2028\u5e74\u306b\u30a8\u30d5\u30ac\u30eb\u30c1\u30ae\u30e2\u30c9\u539f\u85ac\u306e\u7c73\u56fd\u88fd\u9020\u3092\u958b\u59cb.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/FUJIFILM-Biotechnologies-Expands-Strategic-Partnership-with-argenx-to-Include-U.S.-Manufacturing-Operations.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/FUJIFILM-Biotechnologies-Expands-Strategic-Partnership-with-argenx-to-Include-U.S.-Manufacturing-Operations.webp","width":1200,"height":800,"caption":"FUJIFILM Biotechnologies"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"FUJIFILM and argenx Extend Collaboration to U.S. Operations"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/21406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=21406"}],"version-history":[{"count":3,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/21406\/revisions"}],"predecessor-version":[{"id":21429,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/21406\/revisions\/21429"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/21407"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=21406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=21406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=21406"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=21406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}